biomarkers, Parkinson's disease, epigenetics, iPSC-derived stem cells, LRRK2, miRNAs, PSP
Compta Y, Martí MJ, Ibarretxe-Bilbao N, Junqué C, Valldeoriola F, Muñoz E, Ezquerra M, Ríos J, Tolosa E.Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.Mov Disord. 2009 Nov 15;24(15):2203-10.
Sánchez-Danés A, Richaud-Patin Y, Carballo-Carbajal I, Jiménez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM, Memo M, Alberch J, López-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, Raya A.Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.EMBO Mol Med. 2012 May;4(5):380-95.
Botta-Orfila T, Tolosa E, Gelpi E, Sànchez-Pla A, Martí MJ, Valldeoriola F, Fernández M, Carmona F, Ezquerra M.
Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.Neurobiol Dis. 2012 Jan;45(1):462-8. doi: 10.1016/j.nbd.2011.08.033.